Clinical Trial Update: Sirolimus for Advanced Age-Related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated sirolimus for advanced age-related macular degeneration and geographic atrophy; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Age-Related Macular Degeneration, Geographic Atrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-05-09